The soft-shell HBOT market sits inside a regulatory box most buyers do not understand. Every legal soft chamber in the US is cleared by the FDA under 510(k) Class II for one indication only: acute mountain sickness.
Pressure is capped at 1.3 ATA. Everything else marketed for these chambers — recovery, anti-aging, cognitive performance — is off-label.
Inside that box, three chambers dominate the consumer market in 2026. OxyHealth Vitaeris 320, Newtowne Hyperbarics Solace 210, and Summit to Sea Respiro 270.
For context, hard-shell hospital chambers operate in a different regulatory class entirely. Sechrist Industries, Perry Baromedical, ETC Biomedical, and Healing Chambers International build Class A medical-grade systems for clinics — not direct consumer sale.
Aviv Clinics in Florida operates Perry Baromedical hard chambers as part of its Efrati protocol package. Restore Hyper Wellness chains use mid-tier hospital-grade chambers across their footprint. None of those clinic-grade systems compete directly with the three soft chambers reviewed here. See Aviv Clinics evidence vs. marketing for the marketing-vs-evidence breakdown.
The goal is to help you decide if a soft chamber is right for you. And if so, which one.
What soft-shell HBOT actually delivers
At 1.3 ATA, the pressure increase is real but modest. A patient breathing room air at 1.3 ATA sees arterial oxygen tension rise from roughly 100 mmHg to about 130 mmHg, per Tibbles & Edelsberg 1996 in NEJM.
At 2.4 ATA breathing 100% oxygen — the hospital protocol used in most clinical trials — that number reaches 1,500 mmHg or higher. The pharmacology gap is more than tenfold.
This matters because almost every FDA-approved HBOT indication was studied at hospital pressure. The 2015 Cochrane review on diabetic wounds used 2.0 to 2.4 ATA. The Eskes 2010 review on osteomyelitis used 2.4 ATA.
Soft chambers at 1.3 ATA do not replicate that physiology.
What 1.3 ATA can do is well-documented for one thing — reversing acute mountain sickness, which is the FDA-cleared indication. Beyond that, the evidence is sparse and often industry-funded.
At a glance: the three contenders
| Chamber | Pressure | Interior dimensions | Price (2026) | Best for | Standout feature |
|---|---|---|---|---|---|
| OxyHealth Vitaeris 320 | 1.3 ATA | 33" diameter, 90" length | ~$20,000 | Buyers prioritizing track record | Longest market history (since 2002) |
| Newtowne Hyperbarics Solace 210 | 1.3 ATA | 28" diameter, 84" length | ~$9,500 | Budget-conscious buyers | Lowest entry price among major brands |
| Summit to Sea Respiro 270 | 1.3 ATA | 28" diameter, 84" length | ~$12,500 | Buyers wanting a US-built mid-range option | Internal frame design |
All three use the same FDA 510(k) clearance pathway. All three cap at 1.3 ATA. Real differences are in build quality, customer support, warranty terms, and dealer network — not in the underlying therapy.
OxyHealth Vitaeris 320
OxyHealth has the longest commercial track record in the soft-chamber market. The Vitaeris 320 has been sold since 2002. Per the manufacturer's product page, it operates at 1.3 ATA and uses a 32-inch diameter cylinder roughly 90 inches long.
The chamber holds about 320 liters of internal volume. A standard 5-LPM oxygen concentrator pairs with the unit. Full setup runs around $20,000 when chamber, concentrator, and accessories are included.
What the Vitaeris 320 does well
Build quality is the strongest selling point. The chamber uses a polyurethane and reinforced nylon shell with redundant pressure relief valves. Customer reports across two decades suggest seams hold up well to repeated cycling.
The dealer network is the largest in the soft-chamber category. Most regional HBOT clinics that offer mild HBOT use these chambers, which makes replacement parts and service easier to source.
The manufacturer ships globally and has the most extensive third-party test data among soft-chamber makers, including FDA 510(k) clearance K071226.
Where the Vitaeris 320 falls short
The price tag is the highest among the three. At $20,000 fully equipped, buyers are paying a premium for brand history rather than meaningfully different therapy. The chamber operates at the same 1.3 ATA as competitors.
The interior is comfortable but not large. Anyone over 6 feet 2 inches should test fit before buying.
Newtowne Hyperbarics Solace 210
Newtowne Hyperbarics is a Michigan-based manufacturer that has gained share in the budget tier. The Solace 210 is its consumer flagship. Per the manufacturer, it runs at 1.3 ATA inside a 28-inch diameter cylinder roughly 84 inches long.
The Solace 210 prices at roughly $9,500 fully equipped — less than half of the Vitaeris setup. That number includes the chamber, an oxygen concentrator, and basic accessories.
What the Solace 210 does well
Price-to-spec ratio is the obvious win. The chamber meets the same FDA 510(k) standard as the Vitaeris and operates at the same pressure. For buyers whose use case is sleep, recovery, or general wellness — all off-label — the lower price avoids burning capital on brand premium.
Newtowne Hyperbarics's customer service has earned consistent praise in user communities. The company is small enough that buyers often get the founder on the phone for support questions.
The chamber is lighter than the Vitaeris, making installation in a home setting more manageable. A solo installer can usually set it up in two to three hours.
Where the Solace 210 falls short
Track record is shorter. Newtowne Hyperbarics has been selling consumer chambers for roughly a decade.
OxyHealth has more than two decades of field data. For high-cycle users, the long-term durability comparison favors the Vitaeris line.
The dealer network is smaller. If a chamber needs service in a region without a Newtowne Hyperbarics service partner, owners may need to coordinate shipping for repairs.
Summit to Sea Respiro 270
Summit to Sea is a US-based manufacturer that sits in the mid-tier between the two competitors above. The Respiro 270 lists at around $12,500 fully equipped and runs at 1.3 ATA. Interior dimensions are similar to the Solace 210.
The Respiro uses an internal frame design that the manufacturer claims improves pressure distribution. Independent test data on that claim is limited.
What the Respiro 270 does well
Build quality sits between the budget and premium tiers in user reports. The chamber comes with a 5-year warranty on the shell, longer than the standard Newtowne Hyperbarics warranty.
Summit to Sea has a stable US service network through partner clinics. Replacement parts ship from in-country stock, which keeps repair turnaround short.
Where the Respiro 270 falls short
The middle price tier is harder to justify than either alternative. Buyers who want the longest track record will go with the Vitaeris.
Buyers who want the lowest price will go with Newtowne Hyperbarics. The case for paying $3,000 more than the Solace for a similar spec rests on warranty preference.
Marketing materials sometimes describe Respiro 270 features in ways that imply hospital-grade equivalence. Per the FDA clearance, this is not accurate. The chamber operates at 1.3 ATA, well below hospital protocol.
Comparison: which one to pick
The decision usually comes down to three questions.
How long do you plan to use it? Five-plus years of daily use favors the Vitaeris track record from OxyHealth.
Lighter or intermittent use makes the Solace 210 price-to-spec the better call. The Respiro 270 from Summit to Sea splits the difference.
What's your budget? The price brackets break down clearly:
- Under $12,000 — Newtowne Hyperbarics Solace 210
- $12,000 to $15,000 — Summit to Sea Respiro 270
- $18,000 and up — OxyHealth Vitaeris 320 if track record matters most
What is the intended use? All three are FDA-cleared for acute mountain sickness only. If your use is off-label (recovery, wellness, anti-aging), the lower-priced unit is the rational pick.
Pressure and oxygen delivery are equivalent across all three.
What no soft chamber will do
This part is worth being explicit about because the marketing around all three brands routinely blurs it.
No soft chamber at 1.3 ATA replicates hospital HBOT physiology. The arterial oxygen difference is more than tenfold per the NEJM data above.
Studies on chronic wound healing, osteomyelitis, radiation tissue damage, and other UHMS-recognized indications used 2.0 to 2.4 ATA. Those results do not transfer down to 1.3 ATA.
The 2009 Granpeesheh trial on autism at 1.3 ATA found no benefit over sham. The Efrati 2015 long COVID studies — which generated significant marketing buzz — used 2.0 ATA hospital chambers, not soft units. Anti-aging research at the 2020 Tel Aviv telomere study used 2.0 ATA over 60 sessions.
Buyers of any soft chamber should match expectations to the 1.3 ATA evidence base. That base is narrow.
Safety considerations for any soft chamber
All three chambers share the same risk profile because the pressure and oxygen handling are similar.
Middle ear barotrauma is the most common adverse event, with rates between 2% and 10% per the Camporesi 2014 review in Undersea & Hyperbaric Medicine.
Fire risk is the most serious concern. Oxygen environments inside enclosed chambers are flammable. Follow NFPA 99 chamber safety standards for placement, ventilation, and oxygen storage.
Never bring electronics, synthetic clothing, lighters, or any ignition source inside.
Pediatric use should always involve a clinician. Adults with eustachian tube issues, untreated pneumothorax history, or recent ear surgery should consult an ENT before purchase.
Related reading
- Hard chamber vs soft chamber HBOT: real clinical differences
- Home HBOT chamber cost: OxyHealth vs Summit to Sea
- FDA-cleared HBOT chambers: full list and classes
- Best budget soft chambers under $15,000
Frequently asked questions
Is a soft chamber as effective as a clinic visit?
For the only FDA-cleared indication — acute mountain sickness — yes. For everything else, no. Clinical HBOT studies that produced approved indications used 2.0 to 2.4 ATA in hospital chambers. Soft chambers cap at 1.3 ATA, which produces a much smaller increase in arterial oxygen. Off-label benefits at 1.3 ATA are not well-established in published research.
Can I use a soft chamber for diabetic wounds?
The chamber will not deliver hospital protocol pressure. The Cochrane diabetic wound review used 2.0 to 2.4 ATA. Soft chambers at 1.3 ATA were not tested in those trials, and there is no published evidence that 1.3 ATA produces equivalent wound healing. Diabetic wound patients should pursue clinic HBOT through Medicare or insurance, both of which cover the indication.
Does insurance cover a home soft chamber?
In most cases no. Home soft chambers are typically out-of-pocket purchases. Some HSA and FSA accounts have reimbursed soft chambers when prescribed for FDA-cleared indications, but this is uncommon and requires documentation. Medicare does not cover home HBOT equipment for any indication.
What does it cost to run a soft chamber per session?
Operating cost is mostly electricity for the oxygen concentrator, which runs roughly $0.50 to $1.50 per hour-long session at US residential rates. The oxygen concentrator itself needs filter and sieve bed service every 12 to 18 months at $200 to $500. Chamber maintenance is minimal — visual seam inspection, valve testing, and zipper care.
Are any soft chambers FDA-approved for autism or TBI?
No. The FDA 510(k) clearance for every soft chamber sold in the US covers acute mountain sickness only. Off-label use for autism, TBI, ADHD, long COVID, or any other condition is legal but not FDA-approved. Insurance will not cover off-label use. Clinical evidence at 1.3 ATA for these conditions is inconsistent or absent. See the HBOT-for-ADHD evidence in detail for the trial-by-trial ADHD evidence breakdown.
Medical disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Hyperbaric oxygen therapy is investigational for most off-label uses discussed here. Consult your doctor before starting any HBOT protocol, especially if you have pre-existing ear, lung, or cardiovascular conditions. The FDA has not approved soft-shell hyperbaric chambers for any use besides acute mountain sickness.
-- The HBOT Finder Team